Struma ovarii natural history, complications and prognosis: Difference between revisions
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
Line 15: | Line 15: | ||
===Complications=== | ===Complications=== | ||
The most feared complication of struma ovarii is thyrotoxicosis. Other complications include due to metastasis. | |||
===Prognosis=== | ===Prognosis=== |
Revision as of 20:49, 18 August 2017
Struma ovarii Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Struma ovarii natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Struma ovarii natural history, complications and prognosis |
FDA on Struma ovarii natural history, complications and prognosis |
CDC on Struma ovarii natural history, complications and prognosis |
Struma ovarii natural history, complications and prognosis in the news |
Blogs on Struma ovarii natural history, complications and prognosis |
Risk calculators and risk factors for Struma ovarii natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
- Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
- The symptoms of (disease name) typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
The most feared complication of struma ovarii is thyrotoxicosis. Other complications include due to metastasis.
Prognosis
- Prognosis is generally excellent under benign conditions, even in malignant cases, adjuvant iodine-131 ablation with surgical extirpation has excellent prognosis
- The 5/10/20-year mortality/survival rate of patients with Struma ovarii is approximately 96.7%, 94.3%, and 84.9%, respectively.